|
|
Article: No mercy for MRSA: treatment alternatives to vancomycin and linezolid.(methicillin-resistant Staphylococcus aureus)
- Article from:
- Medical Laboratory Observer
- Article date:
- January 1, 2005
- Author:
CopyrightCOPYRIGHT 2005 Nelson Publishing. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The prevalence of both community- and hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) has gone through the roof of our incubators. Some have speculated that the increase may be due to the inappropriate use of third-generation cephalosporins, (1) while others have suggested widespread use of quinolones is responsible. (2)
Laboratorians may not appreciate the extremely limited antibiotic options available to treat MRSA infections. Because many MRSA isolates test clindamycin-resistant, susceptibility reports using the standard Gram-positive panels list vancomycin and linezolid as the only antibiotics to which the offender is sensitive.
...